ReviewGeriatrics (Basel, Switzerland)2026
Appropriateness over Numbers: Pharmacological Burden and Scalable Medication Review in Older Adults.
Review in Geriatrics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polypharmacy in older adults is common, rising and inconsistently defined, and it is widely treated as a problem of how many medicines a person takes. This non-systematic narrative review argues that its harm depends more on the appropriateness of the regimen and the pharmacological burden the regimen imposes, with the number of drugs a partly confounded marker rather than the principal cause. Drawing on evidence published mainly since 2020, it traces the shift from counting medicines to weighting them; the prescribing cascade as a patterned and detectable source of inappropriate use; the explicit criteria (Beers, STOPP/START, EURO-FORTA) and implicit measures (the Medication Appropriateness and Drug Burden indices) that give appropriateness operational form; and the evidence that deprescribing is feasible and generally safe, although its benefit is conditional and depends on how it is done. Because these criteria can be applied to medication lists held in routine data, potentially inappropriate prescribing can increasingly be identified beyond the single encounter and at population scale, even as automated tools remain unreliable at judging whether a flagged criterion applies to the individual patient. The review concludes that medication review should prioritise appropriateness and the individual benefit-risk balance rather than the medication count, and that detection can increasingly be scaled even though the clinical decision and the patient's agreement cannot.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.